4 Topic Commentaries

New To Market

• 

  Joseph S. Ross, MD, MHS

  Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management)

  •

  Yale School of Medicine, Yale University

  In our study, we examined psychoactive medications that were new to market within a therapeutic class that had many alternatives, medications that had been on the market for many years and were much cheaper.

  [Source]
• 

  Nirupa J. Raghunathan, MD, MS

  Director of Pediatric Integrative Medicine; Internist

  •

  Memorial Sloan Kettering Cancer Center

  we don’t have this beautiful recipe where you say, ‘Okay, if I put two drops in, this is what I get out,’

  [Source]
• 

  Scott Gottlieb, MD

  Commissioner of Food and Drugs (2017–2019)

  •

  U.S. Food and Drug Administration

  We’re exploring this approach because we believe that it will enable beneficial and innovative artificial intelligence software to come to market while still ensuring the device’s benefits continue to outweigh it risks.

  [Source]
• 

  Joni L. Rutter, PhD

  Acting Director, National Center for Advancing Translational Sciences (NCATS)

  •

  National Institutes of Health

  Getting approval for a new drug to come to market usually takes years,

  [Source]